Elevation Oncology Announces Appointment of Darcy Mootz, Ph.D., to its Board of Directors
BOSTON, Jan. 22, 2024 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a